黛力新预防化疗药物所致恶心、呕吐的临床观察  

Clinical Observation of Deanxit in Prevention of Chemotherapy-induced Nausea and Vomiting in Lung Cancer Patient

作　　者：张云雷[1] 闵科[1] 邓建良[1] 许春妮[1] 

机构地区：[1]宜兴市人民医院肿瘤科,江苏无锡214200

出　　处：《中国医药指南》2016年第33期11-12,共2页Guide of China Medicine

摘　　要：目的观察黛力新联合盐酸帕洛诺司琼预防含铂类方案肺癌患者化疗所致消化道反应的临床价值。方法将61例肺癌化疗的患者按随机数字表法分为2组,分别为接受常规止吐组(A组)及加用黛力新(B组)治疗,观察2组的止吐效果。结果 B组止吐疗效果显著优于A组。结论黛力新可改善肺癌患者化疗所致消化道反应的效果,提高常规止吐治疗的疗效,改善其生活质量。Objective To observe the clinical effect of deanxit in prevention of chemotherapy-induced nausea and vomiting in lung cancer patients receiving platiniferous chemotherapy. Methods 61 lung cancer patients in chemotherapy were randomly assigned to receive either control group A or intervention group B, the patients in group A were given routine antiemetic drugs, while the group B were given deanxit combined routine antiemetic drugs. The differences in antiemetic effect were compared between the two groups. Results Compared with group A, vomiting and some indicators of life quality were significantly improved in group B. Conclusion Deanxit can increase the effect of routine antiemetie therapy, and improve the quality of life in lung cancer patients with vomiting after chemotherapy.

关 键 词：肺癌 黛力新 帕洛诺司琼 化疗 止吐 

分 类 号：R734.2[医药卫生—肿瘤]